Emmett L - Search Results

1

[¹⁷⁷Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.

Hofman MS, Emmett L, Sandhu S, Iravani A, Joshua AM, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Ng S, Francis RJ, Gedye C, Rutherford NK, Weickhardt A, Scott AM, Lee ST, Kwan EM, Azad AA, Ramdave S, Redfern AD, Macdonald W, Guminski A, Hsiao E, Chua W, Lin P, Zhang AY, McJannett MM, Stockler MR, Violet JA, Williams SG, Martin AJ, Davis ID; TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Hofman MS, et al. Among authors: emmett l. Lancet. 2021 Feb 27;397(10276):797-804. doi: 10.1016/S0140-6736(21)00237-3. Epub 2021 Feb 11. Lancet. 2021. PMID: 33581798 Clinical Trial.

2

Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.

Morigi JJ, Stricker PD, van Leeuwen PJ, Tang R, Ho B, Nguyen Q, Hruby G, Fogarty G, Jagavkar R, Kneebone A, Hickey A, Fanti S, Tarlinton L, Emmett L. Morigi JJ, et al. Among authors: emmett l. J Nucl Med. 2015 Aug;56(8):1185-90. doi: 10.2967/jnumed.115.160382. Epub 2015 Jun 25. J Nucl Med. 2015. PMID: 26112024 Free article.

3

(68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.

van Leeuwen PJ, Stricker P, Hruby G, Kneebone A, Ting F, Thompson B, Nguyen Q, Ho B, Emmett L. van Leeuwen PJ, et al. Among authors: emmett l. BJU Int. 2016 May;117(5):732-9. doi: 10.1111/bju.13397. Epub 2016 Jan 24. BJU Int. 2016. PMID: 26683282

4

Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.

van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, Stricker PD. van Leeuwen PJ, et al. Among authors: emmett l. BJU Int. 2017 Feb;119(2):209-215. doi: 10.1111/bju.13540. Epub 2016 Jun 18. BJU Int. 2017. PMID: 27207581

5

Schwannoma Showing Avid Uptake on 68Ga-PSMA-HBED-CC PET/CT.

Kanthan GL, Izard MA, Emmett L, Hsiao E, Schembri GP. Kanthan GL, et al. Among authors: emmett l. Clin Nucl Med. 2016 Sep;41(9):703-4. doi: 10.1097/RLU.0000000000001281. Clin Nucl Med. 2016. PMID: 27405039

6

Delineating biochemical failure with ⁶⁸Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer.

Hruby G, Eade T, Kneebone A, Emmett L, Guo L, Ho B, Hsiao E, Schembri G, Hunter J, Kwong C. Hruby G, et al. Among authors: emmett l. Radiother Oncol. 2017 Jan;122(1):99-102. doi: 10.1016/j.radonc.2016.11.023. Epub 2016 Dec 28. Radiother Oncol. 2017. PMID: 28040309

7

Lutetium ¹⁷⁷ PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy.

Emmett L, Willowson K, Violet J, Shin J, Blanksby A, Lee J. Emmett L, et al. J Med Radiat Sci. 2017 Mar;64(1):52-60. doi: 10.1002/jmrs.227. J Med Radiat Sci. 2017. PMID: 28303694 Free PMC article. Review.

8

Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis.

Calopedos RJS, Chalasani V, Asher R, Emmett L, Woo HH. Calopedos RJS, et al. Among authors: emmett l. Prostate Cancer Prostatic Dis. 2017 Sep;20(3):352-360. doi: 10.1038/pcan.2017.23. Epub 2017 Apr 25. Prostate Cancer Prostatic Dis. 2017. PMID: 28440324 Review.

9

Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions.

Fanti S, Minozzi S, Morigi JJ, Giesel F, Ceci F, Uprimny C, Hofman MS, Eiber M, Schwarzenbock S, Castellucci P, Bellisario C, Chauvie S, Bergesio F, Emmett L, Haberkorn U, Virgolini I, Schwaiger M, Hicks RJ, Krause BJ, Chiti A. Fanti S, et al. Among authors: emmett l. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1622-1635. doi: 10.1007/s00259-017-3725-1. Epub 2017 May 23. Eur J Nucl Med Mol Imaging. 2017. PMID: 28536833

10

Initial multicentre experience of ⁶⁸ gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited.

Siriwardana A, Thompson J, van Leeuwen PJ, Doig S, Kalsbeek A, Emmett L, Delprado W, Wong D, Samaratunga H, Haynes AM, Coughlin G, Stricker P. Siriwardana A, et al. Among authors: emmett l. BJU Int. 2017 Nov;120(5):673-681. doi: 10.1111/bju.13919. Epub 2017 Jun 20. BJU Int. 2017. PMID: 28548372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page